| Trial ID: | L0181 |
| Source ID: | NCT03196076
|
| Associated Drug: |
Perflutren Lipid Microsphere
|
| Title: |
Contrast-enhanced Ultrasound for Complex Kidney Lesion Diagnosis in Patients With CKD Extension
|
| Acronym: |
CEUS-CKDx
|
| Status: |
COMPLETED
|
| Study Results: |
YES
|
| Results: |
https://ClinicalTrials.gov/show/NCT03196076/results
|
| Conditions: |
Chronic Kidney Diseases|Cystic Kidney Disease
|
| Interventions: |
DRUG: Perflutren Lipid microsphere
|
| Outcome Measures: |
Primary: Number of Participants With Change in Radiologist's Lesion Evaluation, Lesions will be assessed for change in size, calcification, and septation using Bosniak criteria to determine whether a lesion has progressed, regressed or is stable., 1 year |
|
| Sponsor/Collaborators: |
Sponsor: University of North Carolina, Chapel Hill | Collaborators: Lantheus Medical Imaging
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE2
|
| Enrollment: |
25
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: DIAGNOSTIC
|
| Start Date: |
2017-08-28
|
| Completion Date: |
2021-03-19
|
| Results First Posted: |
2021-07-15
|
| Last Update Posted: |
2021-07-21
|
| Locations: |
University of North Carolina of Chapel hill, Chapel Hill, North Carolina, 27599-7510, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT03196076
|
